Euractiv's Advocacy Lab Est. 1min 04-06-2024 Content-Type: Sponsored By, Underwritten Sponsored By An organization or individual has paid to be connected to this work but did not approve or review it.Underwritten Produced with financial support from an organization or individual, yet not approved by the underwriter before or after publication. [shutterstock_2329606493] Euractiv is part of the Trust Project >>> Print Email Facebook X LinkedIn WhatsApp Telegram It is estimated that over 7 million people are living with Alzheimer’s Disease in Europe, and there is increasing concern about the ability to combat the disease with Europe’s ageing population. In this series of articles, Euractiv will explore the state of play with Alzheimer’s Disease, focusing on improving the tools and healthcare infrastructure as it relates to detection, diagnosis and treatment of the disease. Progress on Alzheimer’s Disease stagnating, warns federation chief News | Advocacy Lab Content | Health 04-06-2024 Est. 5minProgress on Alzheimer’s Disease and dementia is stagnating, Alzheimer Disease International CEO Paola Barbarino has warned, yet it’s the most common form of dementia in Europe's elderly.
